Claim · 2023-11-21 · snapshot · Stated in source · Supported

Genentech's release of 21 November 2023 names Aviv Regev as EVP and head of Genentech Research and Early Development (gRED).

One recorded claim. The claim panel gives its qualification, the source passages with their place in each source, and how it was checked.

What it connects

Aviv Regev → held role at → Genentech

Where it appears

No collection page holds this claim. It is listed with its records in the explorer.

Claim and evidence

Aviv Regevheld role at ↓Genentech

Machine-checked, not reviewed by an editorStated in sourceSupported

Supporting evidence: primary · 1 source

Date: 2023-11-21 · snapshot Records dated 2023 →
Role: EVP and head of Genentech Research and Early Development (gRED)

Scope and limitsA historical role snapshot; neither the start nor the end of the role is established.

The evidence 01

primary sourceSupports the claim

Genentech and NVIDIA Enter Into Strategic AI Research Collaboration to Accelerate Drug Discovery and Development

Genentech · 2023-11-21

Cite the original source

Cite the original document, not Selekoa. Check these details against it.

Source excerpt

“said Aviv Regev, EVP and head of Genentech Research and Early Development (gRED).”

Location in source quotation attribution

How it was read Retrieved directly from the publisher

Machine-checked · 2026-10-30

Source details and check notes

Authors: Genentech
Version: Retrieved for the candidate pack on 2026-10-30 (SHA-256 34e7072e1c3903bdeb3e0242032f52a12c492a9c8d0de4d323a7783d456de743). gene.com press release page, dated Tuesday, Nov 21, 2023, as served on 2026-10-30. Its wording can change; earlier wording is not authenticated.
Canonical address: Open the canonical source ↗
Accessed: 2026-10-30
Language: English (en)
Attribution: Genentech, “Genentech and NVIDIA Enter Into Strategic AI Research Collaboration to Accelerate Drug Discovery and Development”, 2023-11-21.
Reuse: No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution.
Check notes: Candidate pack passage, AI in biology (research/ai-in-biology). The quotation (13 words) matched the text retrieved for the candidate pack on 2026-10-30. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. No human editorial review.

Status and meaning

Editorial status. Not reviewed by an editor. An exploratory record that no editor has accepted. This status does not say whether a person has read any linked passage. Each evidence record above shows how it was checked.

Relation. An institutional role with explicitly scoped time: snapshot, sourced interval, or unknown dates. No continuing appointment is implied.

Date. The date identifies this documented announcement or publication; it does not establish a continuing state.

Record ID aib-co-regev-genentech-2023